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Abstract
Background
Fetal exposure to hyperglycemia impacts negatively kidney development and function.
Objective
Our objective was to determine whether fetal exposure to moderate hyperglycemia is asso-
ciated with epigenetic alterations in DNAmethylation in peripheral blood cells and whether
those alterations are related to impaired kidney function in adult offspring.
Design
Twenty nine adult, non-diabetic offspring of mothers with type 1 diabetes (T1D) (case group)
were matched with 28 offspring of T1D fathers (control group) for the study of their leukocyte
genome-wide DNAmethylation profile (27,578 CpG sites, Human Methylation 27 BeadChip,
Illumina Infinium). In a subset of 19 cases and 18 controls, we assessed renal vascular
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development by measuring Glomerular Filtration Rate (GFR) and Effective Renal Plasma
Flow (ERPF) at baseline and during vasodilatation produced by amino acid infusion.
Results
Globally, DNA was under-methylated in cases vs. controls. Among the 87 CpG sites differ-
ently methylated, 74 sites were less methylated and 13 sites more methylated in cases vs.
controls. None of these CpG sites were located on a gene known to be directly involved in
kidney development and/or function. However, the gene encoding DNA methyltransferase
1 (DNMT1)—a key enzyme involved in gene expression during early development–was
under-methylated in cases. The average methylation of the 74 under-methylated sites dif-
ferently correlated with GFR in cases and controls.
Conclusion
Alterations in methylation profile imprinted by the hyperglycemic milieu of T1Dmothers during
fetal development may impact kidney function in adult offspring. The involved pathways seem
to be a nonspecific imprinting process rather than specific to kidney development or function.
Introduction
Fetal programming defines a phenomenon by which an alteration of intrauterine environment
predisposes to the development of disorders later in life. Evidence came from epidemiological
data showing that tobacco exposure, caloric restriction, and severe hyperglycemia during preg-
nancy as well as severe pregnancy-related hypertension are all determinants of low birth weight
[1], which is associated with higher prevalence of metabolic and cardiovascular disorders at
adult age (review in [2]). Hyperglycemia during pregnancy independently of birth weight is
also associated with higher risks of cardio-metabolic disease later in life [3–7].
A reduced number of nephrons has been associated with primary hypertension and renal
and cardiovascular risks in humans [8, 9]. The number of nephrons is determined at birth in
humans [10] and is correlated to birth weight [11], supporting a role of intrauterine environ-
ment on kidney function at adult age.
We previously investigated adult individuals born from type 1 diabetic mothers as a model
of fetal exposure to maternal hyperglycemia, taking those born from type 1 diabetic fathers as
controls [12, 13]. Hence the genetic background in relation to type 1 diabetes is equivalent in
exposed subjects and controls. Data obtained in offspring of type 2 diabetic mothers (4) can be
obscured by the backgrounds of essential hypertension, or other components of the insulin
resistance syndrome so frequently associated with type 2 diabetes. Then, we were able to inves-
tigate the impact of hyperglycemia per se on kidney function. We found that fetal exposure to
maternal type 1 diabetes is associated at adult age with a reduced functional reserve by measur-
ing glomerular filtration rate and effective renal plasma flow [13], a surrogate of functional
nephron numbers [8]. This finding was consistent with studies in a rat model in which moder-
ate hyperglycemia during pregnancy was associated with a decreased number of nephrons in
offspring [14], which favored the development of hypertension at adulthood [15].
The molecular mechanisms involved in the development of impaired renal function in off-
spring of diabetic mothers are yet to be unravelled. Alterations of the expressions of IGFs and
their receptors in fetal kidney were reported in rats exposed in utero to maternal hyperglycemia
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[16]. Because of its impact on kidney development, abnormal angiogenesis may be a plausible
mechanism [17, 18]. In a classical model of angiogenesis, we observed that high glucose levels
induce a defect in angiogenesis by increasing apoptosis and reducing proliferation of endothelial
cells without affecting the expression of several growth factors involved in angiogenesis [19].
If adverse fetal environment irreversibly programs adult disease, then DNA epigenetic mod-
ifications may be involved. DNA methylations and histone modifications are two key epige-
netic changes in chromatin structure that directly influence gene transcription, expression, and
cellular functions and consequently, tissue development [20]. DNA methylation, the most
studied transcriptional epigenetic modification, is characterized by the covalent addition of a
methyl group on a cytosine base by DNAmethyl transferases in CpG dinucleotides (CpG
sites). When CpG methylation occurs in promoter regions of genes, transcription is usually
decreased. It may be thus involved in gene silencing, genomic imprinting, and chromosomal
stability [21] and consequently be a potential mechanism linking hyperglycemia exposure dur-
ing fetal development and renal dysfunction in adulthood [20]. DNA methylation may vary
depending on cell type so that DNA methylation profile may differ from one organ to another,
except if DNAmethylation changes occurred very early in the fetal development.
In the present study we used a microarray technique to seek potential alterations in genome-wide
DNAmethylation in blood cells from adult subjects who had been exposed in utero to maternal
type 1 diabetes. We also investigated whether these alterations are associated with renal dysfunction.
Materials and Methods
Subjects
Participants were direct offspring of type 1 diabetic subjects attending specialized clinics in 6
French hospitals: Hôpital Saint-Louis, Hôpital Bichat–Claude Bernard, Hôtel-Dieu, Institut
Montsouris all in Paris, Centre Hospitalier Universitaire in Poitiers, and Centre Hospitalier
Sud Francilien in Corbeil, Essonne.
Cases and controls were selected to have one parent with type 1 diabetes (as defined by the
American Diabetes Association) for at least two years before offspring conception. Eligibility
was possible if the other parent was not diabetic at time of study. All mothers did not smoke
during pregnancy. Offspring were men or women at least 18 years of age not pregnant at time
of investigation for women and without diabetes as checked with an oral glucose tolerance test.
They were free of immune marker of type 1 diabetes (anti-islet antibodies, antibodies against
GAD, IA2, and IA2 beta, and anti-insulin antibodies). Chronic drug intake, acute infection,
any chronic disease, and personal or family history of kidney disease, other than possible dia-
betic nephropathy in their diabetic parents were excluded. Cases were offspring of type 1 dia-
betic mothers, and controls offspring of type 1 diabetic fathers.
The current study is part of a research program designed to investigate the physiological
consequences of fetal exposure to maternal type 1 diabetes at adult age in 62 offspring recruited
between 2006 and 2009. Genomic DNA isolated from whole blood samples was available for
CpG sites methylation assay in 57 offspring, 29 cases and 28 controls. Among them, 19 cases
and 18 controls were studied for baseline and amino acid-stimulated Glomerular Filtration
Rate (GFR), and Effective Renal Plasma Flow (ERPF), using a 51Cr EDTA plus 123I-hippurate
primed constant infusion technique as previously described [13].
Ethics statement
The study was approved by the local Ethical Committee (Comité Consultatif de Protection des
Personnes dans la Recherche Biomédicale de Paris Saint-Louis; AOR 04032) and each partici-
pant gave a written informed consent to participate.
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Genome-wide DNAmethylation analysis
Methylation of 27,578 CpG sites at 14,475 consensus coding sequencing sites was performed
using the Illumina Human Methylation27 BeadChip system at the Integragen SA at Evry,
France, as previously described [22, 23]. Briefly, 4 ml of bisulfite converted DNA was amplified
overnight at 37°C. The amplified DNA product was fragmented by an endpoint enzymatic pro-
cess. Fragmented DNA was precipitated, resuspended, and applied to an Infinium Human
Methylation27 BeadChip and hybridized overnight. During hybridization, the amplified and
fragmented DNA samples anneal to specific oligomers that are covalently linked to over 27,000
different bead types. Each bead type corresponds to the nucleotide identity and thus the meth-
ylation status at a bisulfite-converted cytosine in a specific CpG site. The bead chips were then
subjected to a single-base extension reaction using the hybridized DNA as a template incorpo-
rating fluorescently labelled nucleotides of two different colors, each corresponding to the cyto-
sine (methylated) or uracil (unmethylated) identity of the bisulfite-converted nucleotide. The
fluorescently stained chip was imaged by the Illumina BeadArray Reader. Illumina’s Genome
Studio program was used to analyze BeadArray data to assign site-specific DNAmethylation
β-values to each CpG site. The β-value defined the proportion of methylation for each subject
at each CpG site which was computed by first subtracting the background signal intensity of
negative controls from both the methylated and unmethylated signals and then taking the ratio
of the methylated signal intensity to the sum of both methylated and unmethylated signals.
Thus, the β-value is a continuous variable ranging between 0 and 1.
Data analyses
Quality control. The detection p-value as provided by Illumina is obtained by comparing
the signal generated by each CpG site to negative controls. CpG sites with missing β-values or
detection p-value> 0.01 for more than 5 patients were eliminated from the analysis. This strat-
egy led to discard 1509 CpG sites (5.5%), thus leaving 26,069 CpG sites among 57 subjects for
the analysis.
Fig 1 illustrates the methylation profile of 4 randomly selected subjects (panel A), showing
that individuals have a peak of low methylated CpG sites, a smaller peak of high methylated
sites, and a small proportion of moderately methylated sites. As an example, Panel B depicts
the distributions of methylations (β-value) at selected CpG sites for the 57 subjects.
Determination of differentially methylated CpG sites between cases and controls. After
initial quality control as described above, a sample of 57 subjects (29 cases and 28 controls) was
tested for association between fetal exposure status and gene-specific methylation. In this anal-
ysis, the logit-transformed β-value of each CpG site was compared between cases and controls
using t-tests. Then, p-values were obtained from B = 100 permutations of the t-statistics as
described in Storey & Tibshirani [24, 25]. More precisely, the exposure status of subjects were
randomly permuted B = 100 times, thus leading to 100 samples where no association between
methylation at each CpG site and exposure is expected (because exposure was mixed across
subjects at random). For each CpG site j, the new artificial “case” and “control” groups were
compared, leading to t-statistics t0bj t
0b
j , b = 1,. . .,B. For a given CpG site i, i = 1,. . .,nCpG nCpG
(= 26,069), the p-value pi was calculated as
pi ¼
XB
b¼1
#fj : jt0bj j  jtij; j ¼ 1; . . . ; nCpGg
nCpG  B
:
CpG sites were considered as differentially methylated if they achieved a p-value below the
pre-specified arbitrary threshold of 0.005. Cut-off p-values commonly used in similar DNA
DNAMethylation in Offspring of Type 1 Diabetic Patients
PLOS ONE | DOI:10.1371/journal.pone.0134654 August 10, 2015 4 / 14
methylation chip studies are set between 0.05 and 0.005 [23, 26]. Average methylation of up-
methylated and down-methylated sites in cases was then computed and its association with
renal parameters analyzed using multiple regression models with the renal parameter as depen-
dent variable and the group (case or control), the average methylation and their interaction as
independent variables.
Analyses were performed using the R statistical programming software (the R foundation
for Statistical Computing, Vienna, Austria)
Identification of biological processes. Further analysis of the differentially methylated
genes was conducted for potential biological significance using an automated method of litera-
ture interrogation, the Acumenta Literature Lab: it identifies and ranks associations existing in
the literature between gene sets, such as those derived from microarray experiments, and
curated sets of key terms such as pathway names, medical subject heading [27]. First, the soft-
ware was questioned with known pathways or genes involved in kidney development and func-
tion such as IGF2, angiogenesis, renin angiotensin system or in renal disease risk such as
APOL1 and MYH9 [28]. In a second step, we ran the software without a priori.
Methylation specific PCR. In order to validate DNAmethylation changes detected by the
genome-wide analysis from Illumina Chip, we performedmethylation specific PCR (Epitect, Qia-
gen) for some most differentially methylated genes accordingly to the manufacturer instructions.
Results
Characteristics of parents and offspring are shown in Table 1. They were similar in the 2 groups
except for the prevalence of late prematurity (born between 34 and 37 weeks of pregnancy)
which was higher in the offspring of diabetic mothers (cases) than in offspring of diabetic
fathers (controls). There was no preterm delivery less than 34 weeks of pregnancy and only one
Fig 1. Distribution of β-values for selected subjects (cases and controls) and CpG sites. Panel A: distribution of β-values for 26,069 CpG sites for four
randomly selected subjects (two among cases, and two among control subjects). Panel B: Distribution of β-values at selected CpG sites for all 57 study
subjects.
doi:10.1371/journal.pone.0134654.g001
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case was born at 34 weeks. In order to seek differences in methylation profile between case and
controls, we looked at the distribution of t-statistics at each CpG sites. We found that the
observed distribution differed from its expectation in case of no difference in DNAmethylation
between case and controls, and was shifted in favor of higher methylation in controls (Fig 2).
As shown in Table 2, 87 CpG sites were differentially methylated between cases and con-
trols. Among them, 74 were down-methylated and 13 sites were up-methylated in cases vs
controls.
Interrogation of the Acumenta Literature Lab did not find methylation differences in
known genes and pathways involved in kidney development and function between cases and
controls. Using the software with no a priori, “Methylation pathway” was identified as the only
pathway strongly (p = 0.0014) associated with down-methylated sites in cases. This was due to
Table 1. Characteristics of parents and offspring.
Controls Cases p
(n = 28) (n = 29)
Diabetic parent characteristics
Sex, men/women 28/0 0/29
Current age, y 56.7 (6.0) 54.2 (6.6) 0.14
Age at diabetes onset, y 17.8 (8.5) 15.5 (8.0) 0.31
Age at offspring birth, y 31.2 (4.8) 27.9 (3.7) 0.006
Current Body mass index, kg/m² 25.5 (3.9) 25.2 (4.1) 0.81
Nephropathy, no. (%) 5 (19) 4 (14) >0.99
Retinopathy, no. (%) 24 (86) 20 (71) 0.33
Macroangiopathy, no. (%) 6 (21) 5 (19) >0.99
Birth data
Preterm delivery, no. (%) 0 (0) 10 (36) 0.003
Birthweight, g 3354 (474) 3282 (661) 0.66
Offspring clinical characteristics
Female gender, no. (%) 14(50) 16 (55) 0.79
Age, y 25.6 (5.0) 25.9 (6.2) 0.85
Body mass index, kg/m² 22.8 (2.8) 23.2 (3.2) 0.63
Systolic blood pressure, mm Hg 122 (13) 123 (14) 0.85
Diastolic blood pressure, mm Hg 67 (10) 69 (9) 0.52
Body fat, % 24.6 (8.0) 26.3 (8.7) 0.46
Men 19.0 (6.1) 19.5 (5.9) 0.86
Women 30.1 (5.4) 31.8 (6.3) 0.47
Waist circumference, cm 80 (9) 77 (9) 0.28
Men 84 (8) 82 (11) 0.73
Women 77 (8) 74 (6) 0.43
Offspring biological characteristics
Serum creatinine, μmol/L 75 (11) 74 (14) 0.78
Uricemia, μmol/L 297 (86) 284 (72) 0.55
Total cholesterol, mmol/L 4.5 (0.9) 4.9 (1.0) 0.093
Triglycerides, mmol/L 0.95 (0.43) 0.98 (0.39) 0.79
LDL cholesterol, mmol/L 2.6 (0.7) 3 (1.1) 0.16
HDL cholesterol, mmol/L 1.5 (0.3) 1.7 (0.6) 0.14
Mean (SD) otherwise stated.
doi:10.1371/journal.pone.0134654.t001
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the DNA (cytosine-5-)-methyltransferase 1 (DNMT1) gene which was less methylated (site
cg15043801) in cases (Fig 3).
To confirm the Illumina Chip analysis, we performed DNAmethylation specific PCR (Epi-
tect, Qiagen) for 7 genes less methylated in offspring of diabetic mothers (DNMT1, TMBIM1,
SOCS6, COL21A1, CCNA1, SURF5, GPR172A). We found that global methylation was lower
in offspring of diabetic mothers: 0.005 (0.024–0.001) [median (75%Q—25%Q)] vs 0.013
(0.055–0.002) in offspring of diabetic fathers (p = 0.004).
We then studied possible relationships between the level of methylation in the differentially
methylated sites between the 2 groups and kidney function parameters. We found an opposite
correlation between the average level of methylation of the 74 sites less methylated in cases and
Glomerular Filtration Rate in basal state (cases: r = 0.27 (95%CI:-0.22;0.66); controls: -0.44
(-0.75;0.03); p = 0.03 for interaction) and in response to amino acid infusion (cases: 0.10
(-0.38;0.54); controls: -0.47 (-0.77;-0.01); p = 0.06 for interaction). Although non-significant, a
similar pattern of correlation was observed between the average level of methylation of the
DNMT1 gene and Glomerular Filtration Rate (basal and stimulated). No correlation was found
with other kidney parameters.
Discussion
Our results suggest that in utero exposure to hyperglycemia is associated with alterations in
genome-wide DNAmethylation profile. These alterations were related to kidney dysfunction
in adults. We did not identify any differential methylation on genes currently known for their
function in kidney development. One explanation could be that DNAmethylation varies
depending on cell type and we do not have evidences that DNAmethylation profile in the kid-
ney is similar to what is observed in peripheral leukocytes, except if DNA methylation changes
occurred in the very early fetal development. Interestingly, one of the strongest observed
Fig 2. Distribution of the t-test statistic.Distribution of the t-test statistic when comparing the β-value of the
26,069 methylation sites between offspring of diabetic fathers (controls) and of diabetic mothers (cases). The
mean of the test is not zero (p<10−12) as expected in case of no difference between the 2 groups.
doi:10.1371/journal.pone.0134654.g002
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Table 2. Details on the 87 differentially methylated sites ranked by p-value. Direction (+) indicates higher methylation in cases and (-) in controls.
SYMBOL Gene name Index p-value Direction
FCN1 ﬁcolin 1 precursor 17386 1.07E-05 -
ERMAP erythroblast membrane-associated protein 17353 6.14E-05 +
MUC5B mucin 5; subtype B; tracheobronchial 22377 0.00016 -
CYP4F3 cytochrome P450; family 4; subfamily F; polypeptide 3 16455 0.00020 -
TMBIM1 PP1201 protein 25876 0.00023 -
SURF5 surfeit 5 isoform a 19999 0.00024 -
DNMT1 DNA (cytosine-5-)-methyltransferase 1 15041 0.00037 -
PROM2 prominin 2 20721 0.00041 -
ORC5L origin recognition complex subunit 5 isoform 1 18297 0.00044 -
C7orf26 hypothetical protein LOC79034 27440 0.00057 -
FGF21 ﬁbroblast growth factor 21 precursor 16223 0.00081 -
FBXO2 F-box only protein 2 1430 0.00096 -
SOCS6 suppressor of cytokine signaling 6 1541 0.0011 -
FLJ20186 differentially expressed in FDCP 8 isoform 1 25192 0.0011 +
KCNQ1 potassium voltage-gated channel; KQT-like subfamily; member 1 isoform 1 16826 0.0011 -
TTLL3 tubulin tyrosine ligase-like family; member 3 isoform 2 3393 0.0011 -
CD209 CD209 antigen 1639 0.0011 -
GNAS guanine nucleotide binding protein; alpha stimulating activity polypeptide 1 isoform a 7256 0.0011 +
C15orf2 hypothetical protein LOC23742 27330 0.0012 +
MYR8 myosin heavy chain Myr 8 18936 0.0012 -
COL21A1 alpha 1 type XXI collagen precursor 5188 0.0013 -
ABHD14A abhydrolase domain containing 14A 4514 0.0014 -
GNAT1 guanine nucleotide binding protein; alpha transducing activity polypeptide 1 6788 0.0015 -
CCNA1 cyclin A1 16506 0.0015 -
SCGB1A1 secretoglobin; family 1A; member 1 (uteroglobin) 9424 0.0016 -
GPR172A G protein-coupled receptor 172A 16693 0.0019 -
CD40 CD40 antigen isoform 1 precursor 21586 0.0020 -
CD40 CD40 antigen isoform 1 precursor 25236 0.0020 -
TMC4 transmembrane channel-like 4 25713 0.0020 -
MGMT O-6-methylguanine-DNA methyltransferase 2946 0.0021 -
KCNB1 potassium voltage-gated channel; Shab-related subfamily; member 1 14740 0.0021 -
NR5A1 nuclear receptor subfamily 5; group A; member 1 724 0.0021 -
NMUR1 neuromedin U receptor 1 18260 0.0021 -
COG2 component of oligomeric golgi complex 2 17060 0.0022 +
C1orf22 hypothetical protein LOC80267 19913 0.0022 -
GTF3A general transcription factor IIIA 24750 0.0022 -
ANXA9 annexin A9 20401 0.0022 -
CTSL cathepsin L preproprotein 11068 0.0023 -
CASKIN2 cask-interacting protein 2 4171 0.0023 -
DNAI1 dynein; axonemal; intermediate polypeptide 1 8523 0.0024 -
CPNE6 copine 6 1566 0.0024 -
SCAP SREBP cleavage-activating protein 26572 0.0024 +
TPCN2 two pore segment channel 2 22462 0.0024 -
PGAM2 phosphoglycerate mutase 2 (muscle) 26033 0.0025 -
BMPR1A bone morphogenetic protein receptor; type IA precursor 6812 0.0025 -
APOB apolipoprotein B precursor 5340 0.0026 -
USP4 ubiquitin speciﬁc protease; proto-oncogene isoform a 18877 0.0027 -
(Continued)
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associations was for the methylation of the gene encoding DNA methyltransferase 1 (DNMT1)
which is known to be involved in early phases of development. Thus, the link between methyla-
tion alteration and kidney dysfunction may result from a nonspecific imprinting process.
Table 2. (Continued)
SYMBOL Gene name Index p-value Direction
DKK2 dickkopf homolog 2 precursor 1409 0.0027 -
FLJ42486 hypothetical protein LOC388021 116 0.0027 +
FLJ32569 hypothetical protein LOC148811 14129 0.0027 -
FBXO17 F-box protein FBG4 isoform 2 8782 0.0027 -
CCDC28B coiled-coil domain containing 28B 13649 0.0027 -
PDE7B phosphodiesterase 7B 2673 0.0028 -
PSENEN presenilin enhancer 2 7811 0.0029 -
DEFA4 defensin; alpha 4 preproprotein 19296 0.0029 -
FLJ36046 hypothetical protein LOC164592 22234 0.0030 -
ITGA8 integrin; alpha 8 13427 0.0030 -
C1orf42 chromosome 1 open reading frame 42 11694 0.0033 -
LRRC15 leucine rich repeat containing 15 26814 0.0033 -
MAGI2 membrane associated guanylate kinase; WW and PDZ domain containing 2 20484 0.0033 -
SLC7A7 solute carrier family 7 (cationic amino acid transporter; y+ system); member 7 19863 0.0034 -
WDR41 WD repeat domain 41 2049 0.0034 -
HOXA2 homeobox A2 9788 0.0035 -
BANF1 barrier to autointegration factor 1 21392 0.0037 -
LSM1 Lsm1 protein 14732 0.0037 +
WFDC12 WAP four-disulﬁde core domain 12 precursor 20441 0.0037 -
LITAF LPS-induced TNF-alpha factor 8221 0.0037 -
SURF6 surfeit 6 18726 0.0037 -
PEG10 paternally expressed 10 6933 0.0038 +
FLJ30707 hypothetical protein LOC220108 3010 0.0038 -
PRLH prolactin releasing hormone 11315 0.0039 -
MRPL18 mitochondrial ribosomal protein L18 10544 0.0039 -
C20orf141 hypothetical protein LOC128653 1274 0.0040 -
PRPF31 pre-mRNA processing factor 31 homolog 13591 0.0040 +
C6orf192 hypothetical protein LOC116843 13501 0.0040 +
ESPN Espin 12998 0.0041 -
CX36 connexin-36 21020 0.0041 -
CGB chorionic gonadotropin beta 3 subunit precursor 554 0.0042 -
EPB41L4B erythrocyte membrane protein band 4.1 like 4B isoform 2 19624 0.0042 -
HLA-DRA major histocompatibility complex; class II; DR alpha precursor 25745 0.0044 -
APOC2 apolipoprotein C-II precursor 27369 0.0044 -
MGC9850 hypothetical protein MGC9850 2325 0.0045 -
SIAHBP1 fuse-binding protein-interacting repressor isoform b 18163 0.0045 -
LOC51315 hypothetical protein LOC51315 8253 0.0047 +
FAM26C hypothetical protein LOC255022 9095 0.0048 -
PEPD Xaa-Pro dipeptidase 9333 0.0050 +
CEACAM4 carcinoembryonic antigen-related cell adhesion molecule 4 21516 0.0050 -
doi:10.1371/journal.pone.0134654.t002
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Our analysis reveals mostly a lower methylation profile in cases with 74 sites less methylated
and 13 sites more methylated when compared to controls. Although permutation analyses
allow calculation of order statistic distributions and multiple-testing adjusted P-values [25], we
cannot exclude false positive or negative results due to the small sample size and the low varia-
tion in site-specific methylation between individuals [22, 23]. Thus, we acknowledge caution in
interpreting the results of differentially methylated genes and the necessity to replicate these
findings in other groups of subjects.
Reduced methylation has been reported with aging [29], smoking [30], gender with
unmethylated X chromosome in males [31], but also with caloric restriction during pregnancy
[32] and with type 2 diabetes [33]. Our data provide for the first time evidence of site-specific
fetal-hyperglycemia association for a certain number of CpG sites which are less methylated in
case of fetal exposure to hyperglycemia.
The positive correlations observed in the case group between renal function and the average
β-value of the 74 CpG sites down-methylated support a potential role for methylation as an
epigenetic phenomenon in the programming of renal dysfunction. In rat models of dietary pro-
tein restriction, the angiotensin receptor gene 1b (AT1b) in the adrenal is significantly under-
methylated early in offspring life, and in vitro, AT1b gene expression is highly dependent on
promoter methylation [34]. Also, fibrogenesis in the kidney is a possible mechanism since epi-
genetic modifications has been shown to cause fibroblast activation [35]. Humans who were
prenatally exposed to famine during the Dutch Hunger Winter in1944–45 had, 6 decades later,
less DNA methylation of the imprinted IGF2 gene compared with their unexposed, same-sex
siblings [32]. Thus, renin-angiotensin system, fibrogenesis and IGF2 gene may be targeted by
epigenetic modifications participating to fetal programing of renal dysfunction. Unfortunately,
in our study, none of the differentially methylated CpGs involved these genes/pathways.
Fig 3. Methylation of the DNA (cytosine-5-)-methyltransferase 1 gene. Distribution of the level of
methylation (β-value) of the DNMT1 gene in offspring of diabetic fathers and offspring of diabetic mothers.
The boxes limits represent first and third quartile of the distribution, with the median inside. Outer whiskers
extend to the most extreme data point which is no more than1.5 times the interquartile range from the box.
p = 0.0004 between the 2 groups.
doi:10.1371/journal.pone.0134654.g003
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Epigenetic mechanisms such as genomic imprinting may contribute to the programming of
health and disease (review in [36]). While most genes are expressed from both parental loci
simultaneously, some only expressed from either the maternal or the paternal allele, are called
parental imprinting genes. Most imprinted genes act during fetal development, making them
plausible candidate for fetal programming [37]. The gene encoding DNAmethyltransferase 1
(DNMT1) was the methylated gene in cases that has been picked up by the automated method
of literature interrogation. It is a key enzyme in maintaining methylation patterns during cell
division and it plays a crucial role in maintaining methylation marks of the imprinted genes
[38] and consequently their expression regulation during development. The deletion of
DNMT1 causes disruption of the maintenance imprinting leading to fetal death in rodents
[39]. It has been shown that hyper-methylation of the DNMT1 promoter is associated with its
decreased expression [40]. Thus, methylation modification of DNMT1may represent a poten-
tial mechanism of fetal programing by hyperglycemia causing abnormal kidney development
through parental imprinting. Changes in gene expression by epigenetic process are not
restricted to imprinted genes. DNMT1 is highly expressed in the kidney and Bechtel et al. dem-
onstrated that it is involved in kidney fibrosis by hypermethylating RASAL1, encoding an
inhibitor of the Ras oncoprotein associated with the perpetuation of fibroblast activation [35].
Lastly, it is also possible that DNMT1 affects gene expression by mechanisms independent of
DNAmethylation, as it has been demonstrated earlier in lung carcinoma [41]. Studying meth-
ylation levels of some imprinted gene in new-born (cord blood) from gestational diabetes, El
Hajj et al recently found an under-methylation of the maternally imprintedMEST gene but
they did not look at DNMT1 [42].
Whether or not fetal exposure to hyperglycemia (or its associated metabolic abnormalities)
impacts tissue DNAmethylation is still unanswered. To our knowledge, no data exist regarding
kidney development and function. However, the relationships between hyperglycemia and
DNAmethylation have been studied in other tissues. Using the same Infinium Methylation
assay than in our study, Volkmar et al. found 266 CpGs with lower methylation levels and only
10 hyper-methylated CpGs in islets isolated from T2D patients compared with non-diabetic
individuals [43]. A subgroup of the differentially methylated genes involved pathways impli-
cated in pancreatic β-cell survival and function. Lastly, El-Osta et al. reported that transient
hyperglycemia induced histone modification on the promoter of the inflammatory gene NFκB
p65 in mice endothelial cells [44].
We cannot rule out that differences in DNAmethylation between cases and controls were
related to prematurity rather than fetal exposure to hyperglycemia. However, prematurity was
late preterm delivery, occurred in a minority of subjects and was not associated with a low
birth weight. In addition other mother environmental factors such as diet, physical exercise,
body weight gain, or stress may impact DNAmethylation.
In conclusion, this study is the first evidence that kidney dysfunction associated with mod-
erate hyperglycemia (or its related metabolic alterations) during fetal development may be
mediated by DNAmethylation modifications. Confirmatory results in other groups of subjects
are needed as well as investigating the direct biological mechanisms linking DNAmethylation
status and kidney function.
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